Inflammatory Bowel Disease Clinical Trial
Official title:
An Investigation Into Handgrip Strength as a Dietetic Assessment Tool to Detect Changes in the Nutritional and Health Status of Adults With Inflammatory Bowel Disease: A Longitudinal Observational Pilot Study
Inflammatory bowel disease (IBD) is a chronic disease, which causes inflammation of the gut.
People with this disease are often poorly nourished. Problems caused by poor nutrition such
as poor wound healing can be reduced if it is recognised and treated early.
When people with IBD attend outpatients clinic with their IBD specialist they are weighed
and their BMI calculated to indicate if they are poorly nourished. Weight and BMI may not
always provide a good assessment of how well nourished a person is because it does not
describe the amount of muscle in the body in proportion to fat. A person with a low or
decreasing amount of muscle but a normal or high BMI is at risk of nutritional problems.
Measuring the amount of muscle someone with IBD has in routine practice poses a challenge to
clinicians due to time constraints. One-way of measuring the amount of muscle a person has
is to measure their muscle strength. This can be measured by recording the strength of a
person's handgrip. Handgrip strength can be measured using a hand-held device called a
dynamometer.
This study aims to test whether it is possible to measure the handgrip strength of people
with IBD attending outpatient's clinic. It also aims to test how the measure obtained
compares with other methods of assessing whether someone is malnourished and their health.
People with a diagnosis of IBD who are aged 18 or older and who are scheduled to attend IBD
outpatients clinic in one hospital will be asked to take part in the study. Their handgrip
strength will be measured each time they attend clinic over a nine-month period in addition
to other information about their health and nutritional state. This study forms part of a
Masters in Research being undertaken with The University of Southampton.
Status | Not yet recruiting |
Enrollment | 25 |
Est. completion date | October 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Adult participants with a confirmed diagnosis of IBD (=18 years of age) 2. People deemed to have capacity to consent 3. People able to understand and read English 4. People attending a gastroenterology outpatient clinic appointment Exclusion Criteria: 1. People physically unable to complete the study procedures 2. Any person who is currently participating in another research trial in which the principle investigator is not satisfied to sign a 12-week exemption form. 3. People involved in an interventional study. 4. People who are currently an inpatient |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Southampton | University Hospital Southampton NHS Foundation Trust. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Handgrip strength measurement | 12 months | No | |
Secondary | IBD Disease activity | 12 months | No | |
Secondary | Quality of life Assessment | 12 Months | No | |
Secondary | Physical Activity Assessment | 12 months | No | |
Secondary | Malnutrition Screening score | 12 months | No | |
Secondary | Micronutrient values | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01557387 -
Real-time Diagnosis of Pseudopolyps During Colonoscopy
|
||
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A |